Bumper Offer - Urjas oil Just @ Rs. 1
Renfor (Intas) is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Kidney transplant.
Medical history of the patient along with age and gender determines the dosage of Renfor (Intas). Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
While these are the most often observed Renfor (Intas) side effects, there are can be others also. These have been listed below. Such side effects of Renfor (Intas) normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Renfor (Intas)'s effect during pregnancy is Moderate and Unknown while nursing. Warnings related to Renfor (Intas)'s effects on the liver, heart and kidney, if any, have been listed below.
Other contraindications of Renfor (Intas) have been discussed in the sections ahead.
Additionally, Renfor (Intas) may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Renfor (Intas), it is important to know that it is safe while driving, and is habit-forming.
Renfor (Intas) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Renfor (Intas) is used -
Moderate
Mild
Is the use of Renfor (Intas) safe for pregnant women?
Renfor can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Renfor right away. Take your doctor's advice before taking it again.
Is the use of Renfor (Intas) safe during breastfeeding?
Information about safety of Renfor for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Renfor (Intas) on the Kidneys?
There can be some harmful effects on your kidneys after taking Renfor. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Renfor (Intas) on the Liver?
You may experience side effects on your liver after taking Renfor. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Renfor (Intas) on the Heart?
Side effects of Renfor rarely affect the heart.
Renfor (Intas) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Renfor (Intas) unless your doctor advises you to do so -
Is this Renfor (Intas) habit forming or addictive?
Forming a habit of Renfor (Intas) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Renfor (Intas) since it does not cause drowsiness.
Is it safe?
Renfor (Intas) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Renfor (Intas) is not used to treat mental disorders.
Interaction between Food and Renfor (Intas)
Information is not available on the interaction of any foods with Renfor (Intas), due to a lack of research on this.
Interaction between Alcohol and Renfor (Intas)
Information about the interaction of Renfor (Intas) and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 880-882
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 883
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cellcept® (mycophenolate mofetil)
